Kevin Bihan

INSERM CIC Paris Est
Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Parkinsonism as a Potential Neurologic Immune-Mediated Adverse Event of Immune Checkpoint Inhibitors.

Parkinsonism as a Potential Neurologic Immune-Mediated Adverse Event of Immune Checkpoint Inhibitors.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: August 10, 2026

Bispecific antibody therapy in multiple myeloma and risk of progressive multifocal leukoencephalopathy.

Bispecific antibody therapy in multiple myeloma and risk of progressive multifocal leukoencephalopathy.

Journal: Blood advances

Published: March 27, 2026

Maternal and Neonatal Complications Associated with Breast Cancer Systemic Treatments-A VigiBase Disproportionality Analysis Study.

Maternal and Neonatal Complications Associated with Breast Cancer Systemic Treatments-A VigiBase Disproportionality Analysis Study.

Journal: Clinical pharmacology and therapeutics

Published: March 22, 2026

Reactive arthritis after treatment with immune checkpoint inhibitors: A case report

Reactive arthritis after treatment with immune checkpoint inhibitors: A case report

Journal: La Revue de medecine interne

Published: December 30, 2025

Respiratory Disorders Associated with Antibody-Drug Conjugates: A Combined Analysis of the French and the WHO Pharmacovigilance Databases.

Respiratory Disorders Associated with Antibody-Drug Conjugates: A Combined Analysis of the French and the WHO Pharmacovigilance Databases.

Journal: Clinical pharmacology and therapeutics

Published: July 09, 2025

Ocrelizumab-induced neutropenia: severity, recurrence, and management. A French national pharmacovigilance study.

Ocrelizumab-induced neutropenia: severity, recurrence, and management. A French national pharmacovigilance study.

Journal: Multiple sclerosis and related disorders

Published: June 18, 2025

Cutaneous adverse drug reactions induced by anticonvulsants: Proposal for allergological work-up and contraindications.

Cutaneous adverse drug reactions induced by anticonvulsants: Proposal for allergological work-up and contraindications.

Journal: Therapie

Published: January 27, 2025

BCR::ABL1 Tyrosine Kinase Inhibitors During Pregnancy, a Disproportionality Analysis of Vigibase.

BCR::ABL1 Tyrosine Kinase Inhibitors During Pregnancy, a Disproportionality Analysis of Vigibase.

Journal: Clinical pharmacology and therapeutics

Published: December 04, 2024

Comedications Associated with Immune-Related Adverse Events from Immune-Checkpoint Inhibitors.

Comedications Associated with Immune-Related Adverse Events from Immune-Checkpoint Inhibitors.

Journal: Clinical pharmacology and therapeutics

Published: November 10, 2024

Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study.

Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study.

Journal: Journal for immunotherapy of cancer

Published: August 06, 2024

Diffuse lung diseases ascribed to drugs: a nationwide observational study over 37 years using the French Pharmacovigilance Database.

Diffuse lung diseases ascribed to drugs: a nationwide observational study over 37 years using the French Pharmacovigilance Database.

Journal: The European respiratory journal

Published: April 26, 2024

Immune Checkpoint Inhibitor Use During Pregnancy and Outcomes in Pregnant Individuals and Newborns.

Immune Checkpoint Inhibitor Use During Pregnancy and Outcomes in Pregnant Individuals and Newborns.

Journal: JAMA network open

Published: April 17, 2024

Showing 1-12 of 49

Last Updated: 09/26/2026